These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8529712)

  • 1. Mechanisms of bilirubin toxicity.
    Amato M
    Eur J Pediatr; 1995; 154(9 Suppl 4):S54-9. PubMed ID: 8529712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of bilirubin on surface tension properties of lung surfactant.
    Amato M; Schürch S; Grunder R; Bachofen H; Burri PH
    Arch Dis Child Fetal Neonatal Ed; 1996 Nov; 75(3):F191-6. PubMed ID: 8976686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.
    Corcoran JD; Berggren P; Sun B; Halliday HL; Robertson B; Curstedt T
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F165-9. PubMed ID: 7820710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of surfactant in rat lungs.
    Bruni R; Fan BR; David-Cu R; Taeusch HW; Walther FJ
    Pediatr Res; 1996 Feb; 39(2):236-40. PubMed ID: 8825793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung.
    Amato M; Petit K; Fiore HH; Doyle CA; Frantz ID; Nielsen HC
    Pediatr Res; 2003 Apr; 53(4):671-8. PubMed ID: 12612208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
    Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acidosis on bilirubin-lipid extract surfactant interaction.
    Amato M; Schürch S; Bachofen H; Burri PH
    Biol Neonate; 1995; 68(5):301-7. PubMed ID: 8835084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.
    Rauprich P; Möller O; Walter G; Herting E; Robertson B
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):817-22. PubMed ID: 10973461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid.
    Merritt TA; Amirkhanian JD; Helbock H; Halliwell B; Cross CE
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):19-22. PubMed ID: 8216215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits.
    Sherman MP; Campbell LA; Merritt TA; Long WA; Gunkel JH; Curstedt T; Robertson B
    J Pediatr; 1994 Dec; 125(6 Pt 1):939-47. PubMed ID: 7996369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung gas volumes and expiratory time constant in immature newborn rabbits treated with natural or synthetic surfactant or detergents.
    Bongrani S; Fornasier M; Papotti M; Razzetti R; Robertson B
    Biol Neonate; 1994; 65(6):406-15. PubMed ID: 8043702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro surface properties of clove oil-phospholipid suspensions with those of ALEC, Exosurf and Survanta.
    Banerjee R; Bellare JR
    Pulm Pharmacol Ther; 2001; 14(2):85-91. PubMed ID: 11273788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.